Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-312022-02-10falseNo description of principal activity10falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 13907472 2022-02-09 13907472 2022-02-10 2023-03-31 13907472 2021-02-10 2022-02-09 13907472 2023-03-31 13907472 c:Director1 2022-02-10 2023-03-31 13907472 d:CurrentFinancialInstruments 2023-03-31 13907472 c:Micro-entities 2022-02-10 2023-03-31 13907472 c:AuditExempt-NoAccountantsReport 2022-02-10 2023-03-31 13907472 c:FullAccounts 2022-02-10 2023-03-31 13907472 c:PrivateLimitedCompanyLtd 2022-02-10 2023-03-31 iso4217:GBP xbrli:pure

Registered number: 13907472









RAYMOND MEDICAL LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2023

 
RAYMOND MEDICAL LIMITED
REGISTERED NUMBER: 13907472

BALANCE SHEET
AS AT 31 MARCH 2023

2023
£


Current assets
40,516

Creditors: amounts falling due within one year
(9,283)

Net current assets
 
 
31,233

Total assets less current liabilities
31,233


Net assets
31,233



Capital and reserves
31,233


Notes


General information

Raymond Medical Limited is a private company limited by shares and is registered in England and Wales. The address of the registered office is 7 Hendon House, Brent Street, London NW4 2NR. 
The principal activity of the company is that of general medical practice activities. 


Average number of employees

The average monthly number of employees, excluding directors, during the period was 1.

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared in accordance with the provisions applicable to entities subject to the micro-entities' regime.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 November 2023.




S.R. Raymond
Director

 
Page 1